The FDA has proposed a new rule that would seek to eliminate the adequate provision guidance in pharma DTC ads.
Washington is alone in legally requiring such proactive outreach to the news media, the Federation of State Medical Boards ...
FDA commish contenders under final review at White House; Inside Eli Lilly’s massive dealmaking spree; Idaho mother charged ...
Procurement conversations have shifted from prioritizing cost savings to seeking partners to transform their organizations.
Spectrum Science, a 2026 MM+M Agency 100 honoree, is elevating chief commercial officer Marie Emms to president of its ...
Naming challenges, combination trials and AI augmentation are forcing pharma brands to establish strategic differentiation ...
Patients seek solutions and trust, two elements that can be elusive. The leaders on this panel at Cannes highlighted how ...
Next year, Medicaid recipients will have to start showing documentation such as a doctor’s note to avoid a new work ...
The FDA's Office of Prescription Drug Promotion issued an untitled letter to Lundbeck over claims on its webpages for the ...
HCPs and patients don’t behave the way you buy. They are not disconnected groups. The leaders on this IQVIA Digital-hosted ...
HCPs and patients don’t behave the way you buy. They are not disconnected groups. The leaders on this IQVIA Digital-hosted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results